Metraipolis › archive › dc_bb00dca2f00f

Brief Report: Real-World Comparative Effectiveness of First-Line Immune Checkpoint Inhibitor Monotherapy Versus Chemo-Immunotherapy in Metastatic NSCLC With… — Europe PMC PMID:42293287

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42293287
DOI: 10.1016/j.jtocrr.2026.101011
License (as archived): solo-consultazione
Archived: 2026-11-02T19:33:39.067Z
SHA-256 of the archived text: 05147e35b3f70e2d7a5d92dbe81b1b19b90b44dab609812b9c62ec3d86708236
Stable URL of this page: https://metraipolis.com/documento/dc_bb00dca2f00f

How to cite

Brief Report: Real-World Comparative Effectiveness of First-Line Immune Checkpoint Inhibitor Monotherapy Versus Chemo-Immunotherapy in Metastatic NSCLC With… — Europe PMC PMID:42293287 — Europe PMC (en), https://europepmc.org/article/MED/42293287 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb00dca2f00f (Metraipolis archive dc_bb00dca2f00f, sha256 05147e35b3f70e2d7a5d92dbe81b1b19b90b44dab609812b9c62ec3d86708236)

BibTeX

@misc{dcbb00dca2f00f,
  title = {Brief Report: Real-World Comparative Effectiveness of First-Line Immune Checkpoint Inhibitor Monotherapy Versus Chemo-Immunotherapy in Metastatic NSCLC With… — Europe PMC PMID:42293287},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42293287},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb00dca2f00f; sha256 05147e35b3f70e2d7a5d92dbe81b1b19b90b44dab609812b9c62ec3d86708236},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42293287. Agents can read the archived copy with the MCP tool read_document.